- Home
- HOOK vs AWX Comparison
HOOK vs AWX Comparison
Compare HOOK & AWX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOOK
- AWX
- Stock Information
- Founded
- HOOK 2011
- AWX 1998
- Country
- HOOK United States
- AWX United States
- Employees
- HOOK N/A
- AWX N/A
- Industry
- HOOK Biotechnology: Pharmaceutical Preparations
- AWX Environmental Services
- Sector
- HOOK Health Care
- AWX Utilities
- Exchange
- HOOK Nasdaq
- AWX Nasdaq
- Market Cap
- HOOK 9.3M
- AWX 9.5M
- IPO Year
- HOOK 2019
- AWX 1998
- Fundamental
- Price
- HOOK $1.25
- AWX $2.45
- Analyst Decision
- HOOK Buy
- AWX
- Analyst Count
- HOOK 4
- AWX 0
- Target Price
- HOOK $10.67
- AWX N/A
- AVG Volume (30 Days)
- HOOK 62.9K
- AWX 18.7K
- Earning Date
- HOOK 08-07-2025
- AWX 08-07-2025
- Dividend Yield
- HOOK N/A
- AWX N/A
- EPS Growth
- HOOK N/A
- AWX N/A
- EPS
- HOOK N/A
- AWX 0.20
- Revenue
- HOOK $9,351,000.00
- AWX $81,005,000.00
- Revenue This Year
- HOOK N/A
- AWX N/A
- Revenue Next Year
- HOOK N/A
- AWX N/A
- P/E Ratio
- HOOK N/A
- AWX $11.97
- Revenue Growth
- HOOK N/A
- AWX N/A
- 52 Week Low
- HOOK $0.72
- AWX $2.07
- 52 Week High
- HOOK $6.77
- AWX $3.99
- Technical
- Relative Strength Index (RSI)
- HOOK 38.94
- AWX 48.16
- Support Level
- HOOK $1.23
- AWX $2.36
- Resistance Level
- HOOK $1.30
- AWX $2.49
- Average True Range (ATR)
- HOOK 0.06
- AWX 0.10
- MACD
- HOOK -0.03
- AWX 0.01
- Stochastic Oscillator
- HOOK 5.97
- AWX 71.43
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.
About AWX Avalon Holdings Corporation
Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.